Rezolute, Inc. (RZLT) Financials

RZLT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 102.2 million 10.4 million
2023-09-30 113.0 million 9.4 million
2023-06-30 123.7 million 7.5 million
2023-03-31 134.2 million 6.9 million

RZLT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -13.0 million 1.8 million
2023-09-30 -10.6 million 1.8 million
2023-06-30 -11.2 million 1.8 million
2023-03-31 -18.0 million 1.9 million

RZLT Net Income

No data available :(

RZLT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 92.6 million - 2.5 million
2023-09-30 98.7 million - 2.3 million
2023-06-30 101.9 million - 2.5 million
2023-03-31 103.1 million 447000 2.4 million

RZLT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 51.4 million
2023-09-30 51.4 million
2023-06-30 51.4 million
2023-03-31 51.4 million

RZLT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 12.0 million 3.2 million 10000
2023-09-30 - 12.2 million 3.7 million -
2023-06-30 153000 10.9 million 3.3 million -
2023-03-31 - 14.2 million 2.9 million -

RZLT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 10000
2023-09-30 - 10000
2023-06-30 - 128000
2023-03-31 - 132000

RZLT

Price: $3.31

52 week price:
0.72
3.59

Earnings Per Share: -1.10 USD

P/E Ratio: -0.96

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 23600

Market Capitalization: 93.5 million

Links: